Data is generated at an exceptionally high rate during each stage of therapeutics development.
However, without the right analytics tools, companies and innovation organizations cannot utilize it for patient benefit. With BullFrog AI, you can unlock the value of your data with meaningful, actionable insights.
Our bfLEAP ™ AI/Unsupervised machine-learning platform identifies relationships and correlations from complex data structures to:
As many new medicines are developed for patients, many are still left undiscovered. The bfLEAP™ platform offers the potential to discover new mechanisms within the clinical data set, that would benefit subgroups of patients. By revitalizing these existing medicine, more therapies become available to help more patients live a better life.
For drug candidates in clinical trials, our bfLEAP™ platform analyzes such clinical trial data sets to predict which patients will respond to a particular therapy in development, thereby tailoring inclusion/exclusion criteria and enhancing primary study outcome success.
your drug development program
on our bfLEAP data requirements to facilitate rapid intake into our technology platform
data to secure cloud environment and we will run bfLEAPTM analyses on your datasets
you with our novel findings
newly gained insights to advance the late-stage clinical development program